FGFR4 antisense oligonucleotides (Verva)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFGFR4 antisense oligonucleotides (Verva)
Drug Alias NameFGFR4 antisense oligonucleotides (University of Queensland)antisense oligonucleotide Fat Blockers (Adipogen)antisense oligonucleotide Fat Blockers (Verva)FGFR4 antisense oligonucleotides (Adipogen)antisense oligonucleotide Fat Blockers (University of Queensland)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdipogen Pharmaceuticals Pty LtdVerva Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A